𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib

✍ Scribed by Guilbert-Douet, N; Morel, F; Bris, M-J Le; Berthou, C; Morice, P; Bourquard, P; Braekeleer, M D

Book ID
110055887
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
83 KB
Volume
18
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The prognosis for patients with chronic
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells
✍ Michael W. N. Deininger; Jorge Cortes; Ron Paquette; Byung Park; Andreas Hochhau πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 380 KB

## Abstract ## BACKGROUND. Clonal cytogenetic abnormalities (CCA) were detected in Philadelphia chromosome (Ph)‐negative cells in some patients with chronic myeloid leukemia (CML) who attained a cytogenetic response to imatinib mesylate. In some patients, CCA/Ph‐negative status was associated with

P107 Chromosomal abnormalities in Philad
P107 Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase
✍ S. Jootar πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 51 KB

6/155), high white cell number (13/155) (red cell unit) or low thrombocyte number (14/125) (thrombocyte unit). Summary: Donors with low hemoglobin levels have to be excluded from the blood donation service for 3 months. So, in theory haemoglobin concentration of all total blood units is suitable for